These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8831086)

  • 1. Pulmonary function in children with homozygous alpha1-protease inhibitor deficiency.
    Wiebicke W; Niggemann B; Fischer A
    Eur J Pediatr; 1996 Jul; 155(7):603-7. PubMed ID: 8831086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
    Bernspång E; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.
    Holme J; Stockley RA
    Chest; 2009 Nov; 136(5):1284-1290. PubMed ID: 19892672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects, results of diagnostic pulmonary function tests and biochemical parameters in children with homozygote alpha-1-antitrypsin deficiency].
    Paul K; Heck B; Schulz V; Ebert W; Trefz G; Feist D
    Pneumologie; 1990 Oct; 44(10):1217-9. PubMed ID: 2281074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha1-Antitrypsin deficiency associated with persistent cutaneous vasculitis. Occurrence in a child with liver disease.
    Brandrup F; Ostergaard PA
    Arch Dermatol; 1978 Jun; 114(6):921-4. PubMed ID: 352272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.
    Steiner SJ; Gupta SK; Croffie JM; Fitzgerald JF
    Dig Dis Sci; 2003 Sep; 48(9):1793-6. PubMed ID: 14561003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.
    Malerba M; Clini E; Cremona G; Radaeli A; Bianchi L; Corda L; Pini L; Ricciardolo F; Grassi V; Ambrosino N
    Respir Med; 2001 Jun; 95(6):520-5. PubMed ID: 11421511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK).
    Campos MA; Kueppers F; Stocks JM; Strange C; Chen J; Griffin R; Wang-Smith L; Brantly ML
    COPD; 2013 Dec; 10(6):687-95. PubMed ID: 23862647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype.
    Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL
    Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphysema.
    Pelham F; Wewers M; Crystal R; Buist AS; Janoff A
    Am Rev Respir Dis; 1985 Oct; 132(4):821-3. PubMed ID: 3876794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homozygous alpha-1 antitrypsin deficiency (PiZZ) and bronchial asthma in childhood--is there a connection?].
    Niggemann B; Claussen M; Koepp P
    Klin Padiatr; 1992; 204(2):98-101. PubMed ID: 1583859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homozygous alpha 1-antitrypsin deficiency. Lung changes in children and adolescents].
    Paul K; Niggemann B
    Monatsschr Kinderheilkd; 1993 May; 141(5):395-400. PubMed ID: 8326958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
    Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1-proteinase inhibitor deficiency and isolated liver cirrhosis without pulmonary emphysema in a 53-year-old female patient].
    Stintzing S; Neureiter D; Hahn EG; Wiest GH
    Dtsch Med Wochenschr; 2005 Dec; 130(49):2823-5. PubMed ID: 16317609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.